Skip to content
Company Analysis

Bluejay Diagnostics, Inc. BJDX

A comprehensive view of key metrics, scores, and financial health for Bluejay Diagnostics, Inc.

Overview of Bluejay Diagnostics, Inc.

BJDX NCM
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Micro Cap
Bluejay Diagnostics, Inc. (BJDX), is a Micro Cap company, in the Medical Devices industry, last closed at $4.89, about 0.0% overvalued vs fair value, -27.2% 1Y return, ranked 1056/1122 in sector.
USD 4.89
3.16%
(Delayed)
• Vol 90d: 147.4%
52-Week Range
Market Cap
$4.65M
Enterprise Value
$1.71M
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Weak
Health
Weak
Efficiency
Fair
Valuation
Weak
Growth
Weak
Profitability
Weak
Health
Weak
Efficiency
Fair
Valuation
Weak
Completeness: 82%
Confidence: 86%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

Website https://bluejaydx.com
HQ Acton, MA
Employees 7
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Insufficient data
Show more details
  • Revenue data missing or non-positive

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$0
Free Cash Flow
$-8.1M
9.9%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

FCF Conversion
105%
Excellent

Free Cash Flow / Net Income — MedTech quality hallmark. ≥100% is typical and desirable; M&A amortisation makes GAAP NI lower than true cash earnings.

Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
0/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Bluejay Diagnostics, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
18
/100
Weak
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Weak
12
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 77% Coverage
Trade-Off Triangle Visualization A ternary plot showing BJDX's balance between Growth (45.1%), Profitability (10.1%), and Safety (44.9%). Growth 45% Safety 45% Profitability 10%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

42th percentile vs peers
43
Key Signals
EPS Growth YoY 98.7% 92p Asset Growth YoY 36.7% 93p Rev Growth YoY -1.00 1p
Strengths
  • EPS Growth YoY in top 20% of peers (98.7%, 92th percentile)
  • Equity/Assets in top 20% of peers (86.1%, 88th percentile)
Risks
  • Rev Growth YoY in bottom 20% of peers (-1.00)

Profitability

9th percentile vs peers
10
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

42th percentile vs peers
43
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Bluejay Diagnostics, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000